周欣羽,王艳芝,魏守刚,邓意辉,王宁,赵静
ZHOU Xin-yu1,WANG Yan-zhi2,WEI Shou-gang3,DENG Yi-hui1,WANG Ning1,ZHAO Jing1(1.School of Pharmacy

• 1:沈阳药科大学药学院
• 2:郑州大学药学院
• 3:阿斯利康贸易有限公司
• 4:沈阳药科大学药学院

摘要(Abstract)：

目的考察齐多夫定棕榈酸酯及其脂质体在小鼠各组织中的降解动力学。方法将齐多夫定棕榈酸酯溶液、齐多夫定棕榈酸酯脂质体分别与小鼠各组织匀浆混合,37℃恒温孵育后,采用HPLC法测定齐多夫定棕榈酸酯浓度。结果齐多夫定棕榈酸酯在小鼠心、肝、脾、肺、肾、脑中的表观降解速率常数(kobs,min-1)依次为:7.5×10-3、5.43×10-2、9.8×10-3、9.9×10-3、2.48×10-2、6.4×10-3。经脂质体包裹的齐多夫定棕榈酸酯在小鼠心、肝、脾、肺、肾、脑组织匀浆中的表观降解速率常数(kobs,min-1)依次为:1.18×10-3、6.70×10-3、1.20×10-3、1.70×10-3、3.00×10-3和1.10×10-3。结论齐多夫定棕榈酸酯及其脂质体在小鼠各组织匀浆中的降解速率不同。经脂质体包裹后,齐多夫定棕榈酸酯在小鼠各组织匀浆中的降解速率降低,表明脂质体对其具有较好的保护作用。
Objective To investigate the degradation pharmacokinetics of azidothymidine palmitate and azidothymidine palmitate liposomes in different homogenate of mice.Methods Azidothymidine palmitate liposomes were prepared by the ipv-alcohol-injection method.Solution of azidothymidine palmitate and azidothymidine palmitate liposomes were incubated with different homogenate of mice at 37 ℃ and then HPLC was used to determine the concentration of azidothymidine palmitate.Results The apparent rate constants(kobs,min-1) of azidothymidine palmitate in different homogenate of mice were as the follows:7.5×10-3,5.43×10-2,9.8×10-3,9.9×10-3,2.48×10-2,6.4×10-3.After entrapped by liposome,the Kobs(min-1) changed to the following:1.18×10-3,6.70×10-3,1.20×10-3,1.70×10-3,3.00×10-3 and 1.10×10-3.Conclusions Degradation rate constants of azidothymidine palmitate and azidothymidine palmitate liposomes in different homogenate of mice are different.After entrapped into liposome,the constants lower,which indicates that liposome has good protective effect on azidothymidine palmitate.

关键词(KeyWords)： 齐多夫定棕榈酸酯;组织降解:药物动力学;脂质体;高效液相色谱法
azidothymidine palmitate;homogenate degradation;pharmacokinetics;liposome;HPLC

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(30371694)

作者(Author): 周欣羽,王艳芝,魏守刚,邓意辉,王宁,赵静
ZHOU Xin-yu1,WANG Yan-zhi2,WEI Shou-gang3,DENG Yi-hui1,WANG Ning1,ZHAO Jing1(1.School of Pharmacy

参考文献(References)：

• [1]马培奇.艾滋病治疗药物最新进展[J].上海医药情报研究,1997(1):7.
• [2]王茜,郑永唐,戎隆富,等.半乳糖神经酰胺脂质体对HIV-1感染性的影响[J].免疫学杂志,2002,18(2):128-131.
• [3]雷杰杰,邓意辉,陈国良,等.齐多夫定棕榈酸酯脂质体的制备及小鼠体内分布[J].中国药学杂志,2005,40(7):538-540.
• [4]MAXWELL D M,BRECHT K M,ONEILL B L.Theeffect of carboxylesterase inhibition on interspecies dif-ferences in soman toxicity[J].Toxicol Lett,1987,39(1):35-42.
• [5]MAXWELL D M,LENX D F,GROFF W A,et al.Theeffect of blood flow and detoxification onin vivocholinesterase inhibition by soman in rats[J].ToxicolAppl Pharmacol,1987,88(1):66-76.
• [6]SILVERMAN R B.The Organic Chemistry of DrugDesign and Drug Action[M].New York:AcademicPress,1993:352-401.
• [7]SCHMIED B.Reducing perinatal transmission by an-tiretroviral therapy[J].Wien Med Wochenschr,1998,148(23/24):550-555.
• [8]刘昌孝,孙瑞元.药物评价实验设计与统计学基础[M].北京:军事医学科学出版社,1999:137-138.